Intrapleural use of tissue plasminogen activator and DNase in pleural infection

Intrapleural use of tissue plasminogen activator and DNase in pleural infection

Afficher d'autres versions (1)

BACKGROUND: More than 30% of patients with pleural infection either die or require surgery. Drainage of infected fluid is key to successful treatment, but intrapleural fibrinolytic therapy did not improve outcomes in an earlier, large, randomized trial. METHODS: We conducted a blinded, 2-by-2 factor...

Description complète

Détails bibliographiques
Auteurs principaux: Rahman, N, Maskell, N, West, A, Teoh, R, Arnold, A, Mackinlay, C, Peckham, D, Davies, C, Ali, N, Kinnear, W, Bentley, A, Kahan, B, Wrightson, J, Davies, H, Hooper, C, Lee, Y, Hedley, E, Crosthwaite, N, Choo, L, Helm, E, Gleeson, F, Nunn, A, Davies, R
Format: Journal article
Langue:English
Publié: 2011

Documents similaires

Documents similaires